Pimavanserin for Sleep in Parkinson Disease

NCT05796167 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The PI did not have eligible candidates. Therefore, Acadia Pharmaceuticals (the sponsor) closed the study.

Conditions

Interventions

Sponsor

State University of New York - Downstate Medical Center

Collaborators